Market Cap
Novartis Market Capitalization:
Novartis AG
CHF212.17 Billion
CHF as of Jan. 1, 2026
US$267.63 Billion
Novartis Main Stock Listing
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—General
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$968.50 B |
|
Johnson & Johnson
|
$499.57 B |
|
AbbVie
|
$405.28 B |
Roche
|
$332.12 B |
AstraZeneca
|
$284.38 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
Lilly
|
$968.50 B |
|
Johnson & Johnson
|
$499.57 B |
|
AbbVie
|
$405.28 B |
|
Roche
|
$332.12 B |
|
UnitedHealth Group
|
$304.72 B |
Company Description
Novartis AG is a global healthcare company that researches, develops, manufactures, and markets healthcare products. It operates through two segments: Innovative Medicines, offering prescription drugs across various therapeutic areas, and Sandoz, which develops, manufactures, and markets finished dosage form medicines, and provides active pharmaceutical ingredients, biosimilars, and biotechnology manufacturing services. Novartis collaborates with various entities to enhance its product offerings.
Stocks & Indices
Novartis AG has the following listings and related stock indices.
Stock: SIX: NOVN
Stock: BCBA: NVS
Stock: Bovespa: N1VS34
Stock: NYSE: NVS
Stock: OTC: NVSEF
Stock: SIX: NOVNEE
Stock: FSX: NOTA
What is a company's market capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.